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Internal ribosome entry site (IRES)
RNA secondary structurehe enterovirus genus in the family Picornaviridae, is the causative agent of
poliomyelitis. Translation of the viral genome is mediated through an internal ribosomal entry site (IRES)
encoded within the 5′ noncoding region (5′ NCR). IRES elements are highly structured RNA sequences that
facilitate the recruitment of ribosomes for translation. Previous studies have shown that binding of a cellular
protein, poly(rC) binding protein 2 (PCBP2), to a major stem-loop structure in the genomic 5′ NCR is
necessary for the translation of picornaviruses containing type I IRES elements, including poliovirus,
coxsackievirus, and human rhinovirus. PCBP1, an isoform that shares approximately 90% amino acid identity
to PCBP2, cannot efﬁciently stimulate poliovirus IRES-mediated translation, most likely due to its reduced
binding afﬁnity to stem-loop IV within the poliovirus IRES. The primary differences between PCBP1 and
PCBP2 are found in the so-called linker domain between the second and third K-homology (KH) domains of
these proteins. We hypothesize that the linker region of PCBP2 augments binding to poliovirus stem-loop IV
RNA. To test this hypothesis, we generated six PCBP1/PCBP2 chimeric proteins. The recombinant PCBP1/
PCBP2 chimeric proteins were able to interact with poliovirus stem-loop I RNA and participate in protein–
protein interactions. We demonstrated that the PCBP1/PCBP2 chimeric proteins with the PCBP2 linker, but
not with the PCBP1 linker, were able to interact with poliovirus stem-loop IV RNA, and could subsequently
stimulate poliovirus IRES-mediated translation. In addition, using a monoclonal anti-PCBP2 antibody
(directed against the PCBP2 linker domain) in mobility shift assays, we showed that the PCBP2 linker domain
modulates binding to poliovirus stem-loop IV RNA via a mechanism that is not inhibited by the antibody.
© 2008 Elsevier Inc. All rights reserved.Introduction
Poliovirus, the prototypic picornavirus, is a small positive-sense RNA
virus with a genome of approximately 7500 nucleotides. The viral
genome is comprised of approximately 900 noncoding nucleotides that
ﬂank a large polyprotein coding region. These 5′ and 3′ terminal
sequences form extensive RNA secondary structures that are utilized to
carry out several essential functions in the poliovirus replication cycle in
infected cells. The RNA secondary structures act as binding sites for both
host and viral proteins to mediate viral gene expression and RNA
replication. One important example of the multiple RNA–protein
interactions that are required during a poliovirus infection is the
interaction of a cellular protein, poly(C)-binding protein 2 (PCBP2), with
stem-loop IV of the 5′ noncoding region (5′ NCR) to mediate cap-
independent translation initiation. Themechanismof actionhas not been
elucidated, but it is likely that PCBP2 binding to poliovirus stem-loop IV
acts to recruit ribosomes via protein–protein interactions or by stabilizing
the RNA structure for internal ribosome entry (Bedard et al., 2007).l rights reserved.In the canonical model of cap-dependent cellular translation, the 5′
7-methyl G cap on themessenger RNA (mRNA) acts to recruit ribosomes
via a direct interaction with the eIF4F cap-binding complex (Merrick,
1990). Unlike cellular mRNAs, picornavirus genomic RNAs lack a 5′ cap
structure and insteadhave aviral protein (termedVPg) that is covalently
linked to the 5′ end of the RNA. VPg is the primer for viral RNA synthesis
but does not function to recruit ribosomes for translation of the viral
genome. Picornaviruses circumvent the need for a 5′ cap structure
bound to an intact eIF4F complex by recruiting ribosomes to the RNAvia
the internal ribosome entry site (IRES) for translation initiation (Pelletier
and Sonenberg, 1988; Jang et al., 1988). The exact mechanism of IRES-
mediated translation initiationhasnot beendetermined;however, it has
beenpostulated that the interaction of trans-acting host factorswith cis-
acting stem-loop structures acts to recruit canonical and non-canonical
translation factors and/or stabilize the RNA for translation.
Several RNA-binding proteins have been identiﬁed as non-
canonical translation factors that stimulate picornavirus IRES transla-
tion, including PCBP2, the La autoantigen, unr (upstream of N-ras),
and polypyrimidine tract binding protein (PTB) (Jang and Wimmer,
1990; Belsham and Sonenberg, 1996; Blyn et al., 1997; Hunt et al.,
1999). PCBP2 was shown to stimulate poliovirus IRES-mediated
translation via its interaction with stem-loop IV of the 5′ NCR (Blyn
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IV RNA that abrogate PCBP2 binding subsequently inhibited viral
translation (Blyn et al., 1995; Gamarnik and Andino, 2000). The
requirement for PCBP2 in translation initiation is speciﬁc to picorna-
viruses containing a Type I IRES, which include poliovirus, coxsack-
ievirus, and human rhinovirus (Walter et al., 1999).
PCBP2 belongs to a class of cellular proteins that bind to poly(C)
stretches of both RNA and DNA (for review see Makeyev and
Liebhaber, 2002). There are 4 isoforms of PCBP, PCBP1–4. Each isoform
contains three K-homology (KH) domains, which are consensus RNA-
binding domains and fold according to a β1α1α2β2β3α3 motif
(Matunis et al., 1992; Siomi et al., 1993; Dejgaard and Leffers, 1996).
The poly(C) nucleotides interact with a groove that is generated
between α1α2 and β2β3 (Du et al., 2004). The co-crystal structure of
the PCBP2 KH1 domain with a 5′-AACCCTA-3′ DNA sequence
corresponding to human telomeric DNA (htDNA) shows that PCBP2
KH1 can independently fold into the β1α1α2β2β3α3 motif (Du et al.,
2004). The crystal structural also reveals that individual PCBP2 KH1
domains can dimerize on exposed surfaces opposite from the
nucleotide binding sites. In addition, PCBP2 KH3 can crystallize with
the same DNA sequence; however, one unique feature is that the
individual KH3 domains were unable to dimerize (Fenn et al., 2007).
Computer modeling of the KH2 domain of PCBP2 shows that it folds
similarly to KH1 and may be capable of dimerization (Du et al., 2007).
To date, the complete PCBP2 protein structure has not been
determined by X-ray crystallography.
Multiple functions have been ascribed to the PCBP proteins. PCBP1
and PCBP2 have been shown to stabilize α-globin mRNAs by direct
interaction with the 3′ NCR (Weiss and Liebhaber, 1995). Likewise, the
interaction of PCBP1/2 with poliovirus stem-loop I of the 5′ NCR has
been shown to stabilize the RNA in vitro (Murray et al., 2001). In
addition tomRNA stability, the interaction of PCBPs with somemRNAs
has also been shown to regulate translation. The interaction of PCBP1,
PCBP2, or hnRNP K with the CU-rich motif of lipoxygenase (LOX)
mRNA silences its expression (Ostareck et al., 1997). In contrast, the
interaction of PCBP1, PCBP2, or hnRNP K with the IRES element of
c-mycmRNA enhances its activity (Evans et al., 2003).
In addition to interacting with mRNAs, PCBPs can also participate
in protein–protein interactions. In yeast two-hybrid screens, it was
shown that PCBP1, PCBP2 and hnRNP K can homodimerize and
heterodimerize (Kim et al., 2000; Bedard et al., 2004). In addition to
variants of PCBPs, PCBP2 has been shown to interact with multiple
RNA-binding proteins, including poly(A) binding protein (PABP) and
two proteins involved in mRNA splicing, SRp20 and 9G8 (Funke et al.,
1996; Wang et al., 1999; Bedard et al., 2007).
Two isoforms, PCBP1 and PCBP2, have been shown to function in the
poliovirus replication cycle. Both PCBP1 and PCBP2 interact with
poliovirus stem-loop I RNA (also known as cloverleaf RNA). The
interaction of PCBP1/2 with poliovirus stem-loop I RNA and the viral
polymerase precursor polypeptide 3CD forms the “ternary complex,” a
ribonucleoprotein complex required for negative strand RNA synthesis
(Andino et al., 1990; Gamarnik and Andino, 1997; Parsley et al., 1997).
Previously, it was demonstrated that PCBP1 and PCBP2 have similar
binding afﬁnities for poliovirus stem-loop I RNA; however, PCBP2 has a
bindingafﬁnity that is 50-foldhigher than thatof PCBP1 for stem-loop IV
RNA (Walter et al., 2002). Also, in HeLa cytoplasmic extracts depleted of
PCBPs, the addition of recombinant PCBP1 failed to rescue poliovirus
IRES-mediated translation, while the addition of recombinant PCBP2
could successfully rescue viral translation (Blyn et al., 1997). Both
isoforms exist in the nucleus and the cytoplasm ofmammalian cells and
share approximately 90% amino acid identity (Makeyev and Liebhaber,
2002). TheN-termini, KH1, KH2, andKH3of PCBP1 and PCBP2 are nearly
identical; however, there are signiﬁcant amino acid differences in the
linker region between the KH2 and KH3 domains (Fig. 1A).
Since the linker region has the greatest amino acid sequence
diversity between PCBP1 and PCBP2, we hypothesized that this regionin PCBP2 acts as an auxiliary domain to augment binding to poliovirus
stem-loop IV RNA and subsequently stimulate cap-independent
translation of the genome. Here we report that PCBP1/PCBP2 chimeric
proteins containing the PCBP2 linker domain, but not the PCBP1 linker
domain,were able to bind stem-loop IV RNA inmobility shift assays and
rescue in vitro poliovirus IRES-mediated translation in HeLa cell extracts
depleted of PCBPs. Moreover, our data from RNA-binding assays using
recombinant PCBP2 and a monoclonal anti-PCBP2 antibody (speciﬁc to
the PCBP2 linker domain) indicate that the PCBP2 linker modulates
binding to poliovirus stem-loop IV RNA via a mechanism that is not
inhibited when complexed with the antibody.
Results
Construction of PCBP1/PCBP2 chimeric proteins
The aim of this study was to determine the basis of the binding
afﬁnity differences between PCBP1 and PCBP2 for poliovirus stem-loop
IV RNA. We focused on the PCBP2 linker region as the domain that is
responsible for the differential binding to poliovirus stem-loop IV RNA
due to the amino acid differences that exist between the linker domains
of PCBP1 and PCBP2 (Fig.1A). The linker regions of both of theseproteins
account for approximately one-third of their size, yet no known
structural motifs have been described for these amino acid sequences.
To test our hypothesis that the linker domain of PCBP2 acts as an
auxiliary domain to augment binding to poliovirus stem-loop IV RNA,
we constructed six chimeric proteins containing different domains of
PCBP1 and PCBP2 (Fig. 1B). The KH1 and KH2 domains of PCBP1 and
PCBP2 are nearly identical, and these regions likely do not contribute to
the observed binding differences. We constructed PCBP1-Linker/P2B
and PCBP2-Linker/P1B by exchanging the linker from the respective
PCBP protein. We predicted that PCBP1-Linker/P2B would represent a
loss-of-function for PCBP2, and PCBP2-Linker/P1B would produce a
gain-of-function for PCBP1. Constructing the PCBP1-Linker and PCBP2-
Linker uncouples the linkers from the KH3 domains and also allowed us
to address the relatively few amino acid differences in the KH3 domains
of PCBP1 and PCBP2. To study the combined activities of the linker-KH3,
we constructed PCBP1-Linker/KH3 and PCBP2-Linker/KH3.
PCBP1/PCBP2 chimeric proteins can interact with poliovirus stem-loop I
RNA
It was previously shown that the interaction of PCBP1 or PCBP2
with poliovirus stem-loop I RNA is an important step in viral RNA
replication (Gamarnik and Andino, 1997; Parsley et al., 1997; Walter
et al., 2002) [refer to the predicted stem-loop I structure in Fig. 2A]. The
apparent binding afﬁnities of PCBP1 and PCBP2 for poliovirus stem-
loop I RNA are similar, with the afﬁnity of PCBP2 for stem-loop I RNA
being slightly higher (about two-fold) than PCBP1 for the same RNA
(Walter et al., 2002). To determine if the puriﬁed PCBP1/PCBP2
chimeric proteins were properly folded and active in RNA binding,
we performed electrophoretic mobility shift assays with poliovirus
stem-loop I RNA (Fig. 2B). With the exception of PCBP1-Linker/P2B,
(Fig. 2B, lanes 6 and 7), all of the PCBP1/PCBP2 chimeric proteins were
able to interact with poliovirus stem-loop I RNA with nearly equal
relative afﬁnities. We repeated themobility shifts assays for poliovirus
stem-loop I RNA with different preparations of PCBP1-Linker/P2B
proteins multiple times and observed the same results (data not
shown). When compared to the PCBP1 linker-containing chimeric
proteins, the relative afﬁnities of PCBP2 linker-containing chimeric
proteins for poliovirus stem-loop I RNA are about 2-fold greater, in
agreement with previous results (Walter et al., 2002). The mobility
shift assay shows that our PCBP1/PCBP2 chimeric proteins are properly
folded and functionally active in binding to RNA. It should benoted that
the different preparations of PCBP1-Linker/P2B have all displayed
the same lack of binding to stem-loop I RNA, suggesting that this
Fig. 1. Domain compositions of PCBP1/PCBP2 chimeric proteins. A. Amino acid sequence alignment of PCBP1 and PCBP2. The amino acid sequences of the KH domains are boxed in
green. The amino acid sequences of KH1 and KH2 are nearly identical, with slight differences in KH3 and major differences in the linker region between the KH2 and KH3 domain.
Amino acid differences are denoted in red and amino acids that only exist in the PCBP2 linker are denoted in blue. Dashes indicate the absence of a corresponding amino acid in one
protein or the other. B. Schematic of the PCBP1/PCBP2 chimeric proteins. The proteins were constructed using restriction sites that were introduced at the interface of the KH2/linker
(XhoI) and linker/KH3 (NheI) into a pET22 expression plasmid. KH domain and linker sequences from PCBP1 are indicated by white boxes while those from PCBP2 are indicated by
black boxes.
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misfolded.
PCBP1/PCBP2 chimeric proteins can dimerize with GST-PCBP2
Using yeast two-hybrid assays, Bedard and colleagues showed that
PCBP2 can homodimerize and heterodimerize with PCBP1 in vivo. The
dimerization domain of PCBP2 was mapped to the KH2 domain;however, the study did not identify the dimerization domain of PCBP1
(Bedard et al., 2004). The dimerization of PCBP2 was shown to be
important for poliovirus IRES-mediated translation (Bedard et al., 2004).
It was also predicted that dimers of PCBP1 interact with the c-myc IRES
to stimulate translation (Evans et al., 2003). To assess the protein–
protein interaction capabilities of the PCBP1/PCBP2 chimeric proteins,
we performed GST pull-down assays with GST-PCBP2 (Fig. 3). The GST
pull-down results showed that all of the PCBP1/PCBP2 chimeric proteins
Fig. 2. Characterization of PCBP1/PCBP2 chimeric proteins. A. Mfold predicted RNA secondary structure of stem-loop I (Mathews et al., 1999; Zuker, 2003). The nucleotide constraints
were determined by chemical and enzymatic structure probing (Skinner et al., 1989). The structure shown represents nucleotide 1 to 98 for the poliovirus type 1 genomic RNA.
Poliovirus stem-loop I is predicted to form a cloverleaf-like structure. Stem-loop b and the c-rich spacer sequence, boxed, have been shown to interact with PCBP1/2 (Parsley et al.,
1997; Toyoda et al., 2007). B. Electrophoretic mobility shift assay of PCBP1/PCBP2 chimeric proteins with poliovirus stem-loop I RNA. In vitro transcribed [32P] UTP-labeled poliovirus
stem-loop I RNA at a ﬁnal concentration of 0.1 nM was incubated with 50 or 100 nM of puriﬁed recombinant PCBP1/PCBP2 chimeric protein for 10 min at 30 °C, and the reactionwas
resolved by native polyacrylamide gel electrophoresis. Lanes 1 and 16 show the RNA in the absence of protein. Lanes 2–5, 8–15 and 17–18 show ribonucleoprotein (RNP) complexes
formed by the interaction of the PCBP1/PCBP2 chimeric proteins with the RNA. The RNP complexes are denoted by the upper arrow. The samples in lanes 16–18 were subjected to
electrophoresis for an additional hour (compared to those samples in lanes 1–15), thus accounting for the increased distance between the RNP complex and the free RNA. Lanes 6–7
show that the PCBP1-Linker/P2B chimera is unable to interact with poliovirus stem-loop I RNA.
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In agreement with previously published results, the interaction of GST-
PCBP2 with wild type PCBP1 appears to be one of higher afﬁnity than
with wild type PCBP2, suggesting that PCBPs may function as
heterodimers (Fig. 3, lane 1) (Bedard et al., 2004). Interestingly,
PCBP1-Linker/P2B, which is inactive in RNA binding, can dimerize
withGST-PCBP2 (Fig. 3, lane 7). The GST pull-down assay shows that our
PCBP1/PCBP2 chimeric proteins are properly folded and can function in
protein–protein interactions with GST-PCBP2.
The PCBP2 linker augments binding to poliovirus stem-loop IV RNA
Individually, the KH domains of PCBP1 and PCBP2 fold into a
predicted RNA-binding motif (Siomi et al., 1993). It has been shownthat PCBP2 KH1 is required for binding to poliovirus stem-loop I and IV
RNA (Silvera et al., 1999; Walter et al., 2002). Charge-to-alanine
mutations made in the PCBP2 KH3 domain reduced binding to
poliovirus stem-loop I RNA, but eliminated binding to poliovirus stem-
loop IV RNA, suggesting differential KH domain utilization in RNA
binding (Walter et al., 2002). We postulated that the observed
differences in binding to poliovirus stem-loop IV RNA (refer to the
predicted stem-loop IV structure in Fig. 4A) are a result of the linker
domain, since this domain has the greatest amino acid differences
between the two proteins, including nine extra amino acids in the
PCBP2 linker. To test our hypothesis that the PCBP2 linker augments
binding to poliovirus stem-loop IV RNA, we performed electrophoretic
mobility shift assays (Fig. 4B). The mobility shift assays conﬁrmed
our previous ﬁnding that at low concentrations, PCBP1 is unable to
Fig. 3. GST pull-down assays of GST-PCBP2 and PCBP1/PCBP2 chimeric proteins. GST-PCBP2 (2 μg) and His-tagged PCBP1/PCBP2 chimeric proteins (5 μg) were subjected to pull-down
assays as described in Materials and methods. Lanes 1–16 show the variable interaction of GST-PCBP2 with the PCBP1/PCBP2 chimeric proteins over GST alone (i.e., non-speciﬁc
background interactions). Lanes 1–2 and 9–10 show the interactions of wild type PCBP1 and PCBP2 with GST-PCBP2 and GST (control), respectively.
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RNA (compare Fig. 4B, lanes 2 and 3 with 10 and 11, respectively). The
PCBP1 linker-containing chimeric proteins, PCBP1-Linker, PCBP1-
Linker/KH3, and PCBP1-Linker/P2B, were unable to interact with
poliovirus stem-loop IV RNA (Fig. 4B, lanes 4–9). All of the PCBP2
linker-containing chimeric proteins interacted with stem-loop IV RNA
(Fig. 4B, lanes 12–17). The apparent afﬁnity of wild type PCBP2 for
poliovirus stem-loop IV RNA is high, with a KD of 15 nM; so all of the
RNA probe was bound using a minimum protein concentration of
50 nM (Gamarnik and Andino, 2000). The relative afﬁnity of PCBP2-
Linker/KH3 for poliovirus stem-loop IV RNA (Fig. 4B, lane 14) appears
to be reduced, compared to the rest of the PCBP2 linker-containing
chimeric proteins; however, the mobility shift assay data with
poliovirus stem-loop I RNA (Fig. 2B, lanes 12 and 13) suggest that
the overall RNA-binding activity of this protein preparation is reduced
compared to the other PCBP2 linker-containing chimeric proteins.
Taken together, our data from the mobility shift assays demonstrate
that the PCBP2 linker is a major determinant for binding to poliovirus
stem-loop IV RNA.
PCBP2 linker-containing chimeric proteins rescue poliovirus IRES-mediated
translation
The interaction of PCBP2 with poliovirus stem-loop IV RNA is
required for poliovirus IRES-mediated translation (Blyn et al., 1997).
Mutationsmade to poliovirus stem-loop IV RNA that inhibit binding to
PCBP2 also abrogate IRES-mediated translation (Gamarnik and
Andino, 2000). We have previously demonstrated that translation of
a reporter RNA in HeLa S10 cytoplasmic extract depleted of PCBPs is
inefﬁcient; however, upon addition of recombinant PCBP2, poliovirus
IRES-mediated translation can be rescued (Walter et al., 1999, 2002).
To determine if the PCBP1/PCBP2 chimeric proteins can stimulate
poliovirus IRES-mediated translation, we performed in vitro transla-
tion assays using a reporter RNA in the absence and presence of the
PCBP1/PCBP2 chimeric proteins. Translation of the luciferase reporter
RNA is driven by the IRES of poliovirus. PCBP was depleted from HeLaS10 cytoplasmic extract via poly(rC)-sepharose afﬁnity chromatogra-
phy, and depletion was conﬁrmed by Western blot (Fig. 5A). Mock
depletion of the HeLa S10 was also carried out to control for non-
speciﬁc depletion of cellular factors that are important in translation.
Cap-independent translation of the luciferase reporter RNA in PCBP-
depleted HeLa cytoplasmic extract is inefﬁcient [compare mock-
depleted to PCBP-depleted (Fig. 5B)]. Addition of PCBP1 linker-
containing chimeric proteins to the PCBP-depleted extract caused a
slight stimulation of translation (1–2 fold); however, addition of
PCBP2 linker-containing chimeric proteins signiﬁcantly stimulated
poliovirus IRES-mediated translation (12–26 fold) (Fig. 5B). The level
of rescue varied between the PCBP2 linker-containing chimeric
proteins, as summarized at the bottom of Fig. 5B. The lower levels of
rescue observed for PCBP2-Linker/KH3 might be due to the lower
speciﬁc activity of that protein preparation that is seen in the mobility
shift assays with poliovirus stem-loop I and IV RNAs (refer to Figs. 2B
and 4B). The in vitro translation assays show that PCBP2 linker-
containing chimeric proteins signiﬁcantly stimulated translation,
supporting previous conclusions that PCBP2 binding to poliovirus
stem-loop IV RNA mediates, in part, IRES-dependent translation.
The linker region of PCBP2 does not interact directly with poliovirus
stem-loop IV RNA
We demonstrated that PCBP2 linker-containing chimeric proteins
can bind to poliovirus stem-loop IV RNA and stimulate IRES-mediated
translation. One possible explanation for how the PCBP2 linker
modulates binding to poliovirus stem-loop IV RNA is an increased
domain ﬂexibility of the linker due to the extra nine amino acids. We
postulate that the increased ﬂexibility of the PCBP2 linker strengthens
the RNA–protein interaction of the adjacent KH domains for poliovirus
stem-loop IV RNA. To further extend our studies on the PCBP2 linker,
we examined the effects of adding a monoclonal anti-PCBP2 antibody
that appears to recognize the PCBP2 linker region (at least in denatured
preparations of protein) to our in vitro assays. As a control, we utilized a
polyclonal anti-PCBP antibody that is not speciﬁc for the PCBP2 linker.
248 P. Sean et al. / Virology 378 (2008) 243–253The Coomassie-stained, SDS-polyacrylamide gel of the PCBP1/PCBP2
chimeric proteins and Western blot analysis using the monoclonal
anti-PCBP2 antibody show that the antibody only recognizes wild
type PCBP2 and PCBP2 linker-containing chimeric proteins (Fig. 6A),suggesting that amino acid sequences within the PCBP2 linker domain
form the major epitope recognized by the monoclonal antibody in
denatured preparations of protein. Interestingly, Western blot analysis
using the polyclonal anti-PCBP antibody shows that this antibody
249P. Sean et al. / Virology 378 (2008) 243–253recognizes wild type PCBP1, PCBP2 and all of the PCBP1/PCBP2
chimeric proteins, indicating that some of the recognized epitopes
are shared between PCBP1 and PCBP2 (data not shown).
To further dissect the contributions of the PCBP2 linker domain to
RNA binding, we performed electrophoretic mobility shift assays of
PCBP2 and poliovirus stem-loop IV RNA in the presence of either the
monoclonal anti-PCBP2 or polyclonal anti-PCBP antibodies (Fig. 6B).
The puriﬁed IgG fractions from these antibodies do not interact with
the radio-labeled poliovirus stem-loop IV RNA non-speciﬁcally, as
expected (Fig. 6B, lanes 2–3); adding increasing amounts of recombi-
nant PCBP2 yielded a dose-dependent increase in RNP complex
formation, indicating RNA–protein interaction (Fig. 6B, lanes 4–5).
Addition ofmonoclonal anti-PCBP2 antibody tomobility shift assays of
PCBP2 andpoliovirus stem-loop IVRNA resulted in a super-shiftedRNP
complex (Fig. 6B, lanes 6–7). Addition of the polyclonal anti-PCBP2
antibody failed to super-shift the RNP complex, suggesting that signif-
icant numbers of PCBP2 epitopes recognized by this antibody prep-
aration are masked when stem-loop IV–PCBP2 RNP complexes are
formed (Fig. 6B, lanes 8–9). We also examined the effect of adding
puriﬁed IgG corresponding to either monoclonal anti-PCBP2 antibody
or polyclonal anti-PCBP antibody to in vitro translation assays of a
poliovirus-IRES reporter RNA in HeLa S10 cytoplasmic extract and
found that addition of either antibody had no effect on poliovirus IRES-
mediated translation (data not shown). Addition of either monoclonal
anti-PCBP2 or polyclonal anti-PCBP antibody to an EMCV IRES-
mediated in vitro translation reaction did not inhibit translation,
indicating that the antibody did not exert any non-speciﬁc inhibitory
effects (data not shown). The data from the in vitro assays using the
monoclonal anti-PCBP2 antibody showed that PCBP2 can still function
in RNA binding and translation stimulation even when the linker is
bound by an antibody.
Discussion
During a poliovirus infection, the viral proteinase 2A cleaves eIF4G
and poly(A) binding protein (PABP), a binding partner of eIF4G that
interacts with the 3′ poly(A) tract of cellular mRNAs to functionally
circularize the template for synergistic enhancement of translation
(Tarun and Sachs, 1996). These cleavage events lead to the inhibition of
cap-dependent translation (Kräusslich et al., 1987; Gradi et al., 1998;
Joachims et al., 1999; Kerekatte et al., 1999; Liebig et al., 2002). Poliovirus
is not affected by this shut down of cap-dependent translation because it
utilizes an IRES-mediated translation mechanism (Pelletier and Sonen-
berg, 1988). IRES-mediated translation also occurs for some cellular
mRNAs,whichmaybeamechanism toensure expressionof vital proteins
during situations of reduced cap-dependent translation (in addition to
viral infection), such as hypoxia, amino acid starvation, and cell cycling.
Consistent with this, the majority of cellular IRESes discovered so far
mediate the translation of proteins involved in cell cycle progression,
differentiation, or apoptosis (Stoneley and Willis, 2004). With an
alternative translation mechanism already in place in human cells,
infectionbypoliovirus exploits cellular components to its ownadvantage.
The utilization of PCBP2 and PCBP1 by poliovirus to mediate important
viral functions such as translation and RNA replication is not surprising,
considering the multi-functional properties of the PCBPs, resulting from
their ability to interact with both nucleic acids and proteins.
Previously, Dejgaard and Leffers showed that individually-expressed
KH1 and KH3 domains of PCBP1 and PCBP2 had high afﬁnity and broadFig. 4. The PCBP2 linker mediates binding to poliovirus stem-loop IV RNA. A. Mfold predicted
constraints were determined by chemical and enzymatic structure probing (Skinner et al., 198
RNA. Poliovirus stem-loop IV is predicted to form a cruciform-like structure. Loops a and b,
2000). B. Electrophoretic mobility shift assay of PCBP1/PCBP2 chimeric proteins with poliovir
at a ﬁnal concentration of 1 nMwas incubated with 50 or 100 nM of puriﬁed recombinant PCB
polyacrylamide gel electrophoresis. Lane 1 shows the electrophoretic mobility of the RNA pro
containing chimeric proteins with the RNA. Lanes 10–17 show the formation of ribonucleopro
the RNA. The RNP complexes are denoted by the upper arrow.speciﬁcity for RNA substrates in vitro (Dejgaard and Leffers, 1996). They
also presented data showing that the KH2 domain from either protein
exhibited poor RNA-binding activity. In another study, when individual
KH domains of PCBP2 were expressed, only KH1 was able to interact
with bothpoliovirus stem-loop I and IVRNAs in electrophoreticmobility
shift assays (Silvera et al., 1999). It was also shown that charge-to-
alanine mutations in amino acids of KH1 or KH3 predicted to interact
with RNA eliminated binding to poliovirus stem-loop IV RNA (Walter
et al., 2002). Taken together, these results suggested that the correct
amino sequences and intact KH domains of PCBP2 are required for
proper protein folding and binding to poliovirus stem-loop IV RNA.
As noted above, PCBP1 and PCBP2 have distinct functions in the
poliovirus life cycle. While both PCBP1 and PCBP2 interact with
poliovirus stem-loop I RNA and mediate, in part, negative strand RNA
synthesis, only PCBP2 binds to poliovirus stem-loop IV RNAwith high
afﬁnity, an interaction required for cap-independent translation. Due
to the amino acid differences that exist in the linker region between
PCBP1 and PCBP2, including nine extra amino acids PCBP2 linker, we
predicted that the linker region of PCBP2 is the domain responsible for
the ability to bind to poliovirus stem-loop IV RNA. The observed
binding differences may, in part, be attributed to the secondary
structure of the target RNA sequences. The secondary structure of
poliovirus stem-loop I RNA presents two potential PCBP binding sites,
stem-loop b and the c-rich spacer sequence (Fig. 2A) (Gamarnik and
Andino,1997; Parsley et al., 1997; Toyoda et al., 2007). The interactions
of PCBP2with these binding sites require just two KH domains (Walter
et al., 2002; Perera et al., 2007). In the case of poliovirus stem-loop IV
RNA, the RNA secondary structure ismore extensive andpresents three
potential PCBP2 binding sites. RNase foot-printing analysis of PCBP2
with poliovirus stem-loop IV RNA revealed three regions of the RNA,
loop a, loop b and bulge c that are protected by PCBP2 (Fig. 4A)
(Gamarnik and Andino, 2000). We speculate that the interaction of
PCBPs with poliovirus stem-loop IV RNA requires three KH domains
and that each region of the RNA may interact with an individual KH
domain of PCBP2. However, since PCPB2 is known to dimerize, the
exact number of PCBP2 molecules required to interact with poliovirus
stem-loop IV RNA has yet to be determined. We suggest that the nine
extra amino acids of the PCBP2 linker domain (compared to PCBP1)
extends this region and allows greater structural ﬂexibility to
accommodate the interactions of KH2 and KH3 with the RNA. Such
ﬂexibility may strengthen the overall interaction of the protein with
the RNA. For PCBP1, we predict that the shorter, more rigid linker
domain does not allow optimal binding of the KH2 and/or KH3
domains with the respective RNA motifs to poliovirus stem-loop IV.
In this report, we have presented evidence that the linker region of
PCBP2 is the domain responsible for its increased binding to poliovirus
stem-loop IV RNA compared to PCBP1 interacting with the same RNA.
Initially, via electrophoretic mobility shift assays with poliovirus stem-
loop I RNA and GST-pull-downs with GST-PCBP2, we showed that the
PCBP1/PCBP2 chimeric proteins (except PCBP1-Linker/P2B) were active
in RNA binding, and all six were active in protein–protein interactions.
The electrophoretic mobility shift assays with poliovirus stem-loop IV
RNA clearly showed that only PCBP2 linker-containing PCBP1/PCBP2
chimeric proteins were able to interact with the RNA. Data from our in
vitro translation experiments using HeLa cell cytoplasmic extracts
depleted of PCBP showed that only addition of PCBP2 linker-containing
PCBP1/PCBP2 chimeric proteins rescued poliovirus IRES-mediated
translation. The electrophoretic mobility shift assays using theRNA secondary structure of stem-loop IV (Mathews et al., 1999; Zuker, 2003). Nucleotide
9). The structure shown represents nucleotide 230 to 444 for poliovirus type 1 genomic
and bulge c, boxed, have been identiﬁed to interact with PCBP2 (Gamarnik and Andino,
us stem-loop IV RNA. In vitro transcribed [32P] UTP-labeled poliovirus stem-loop IV RNA
P1/PCBP2 chimeric proteins for 10 min at 30 °C, and the reactionwas resolved by native
be in the absence of added protein. Lanes 2–9 show the incubation of the PCBP1 linker-
tein complexes by the interaction of the PCBP2 linker-containing chimeric proteins with
Fig. 5. Addition of PCBP2 linker-containing chimeric proteins to PCBP-depleted cytoplasmic extracts rescues poliovirus IRES-mediated translation. A. Western blot analysis of HeLa S10
cytoplasmic extract depleted of PCBP. A total of 50 μg of protein from HeLa cell cytoplasmic extract or HeLa cell cytoplasmic extract depleted of PCBPs via poly(rC)-sepharose afﬁnity
chromatographywas resolved by SDS-PAGE, transferred to a PVDFmembrane, andprobedusing amonoclonal anti-PCBP2 antibody. Lane1 shows themolecularweight ladder, L. Lanes 2–4
display the non-depleted HeLa S10 (N), mock-depleted HeLa S10 (M) and PCBP-depleted HeLa S10 (D). B. Luciferase assays measuring the in vitro translation of PV 5′ NCR-luc RNAwith
PCBP1/PCBP2 chimeric proteins.We incubated50 fmol of PV5′NCR-lucRNAand100nMofPCBP1/PCBP2 chimeric proteins in PCBP-depletedHeLa S10 cytoplasmic extract for 2.5 h at 30 °C
and assayed for luciferase activity. The relative light unit (RLU) values are averages from three separate reactions. The error bars are standard deviations from the mean.
250 P. Sean et al. / Virology 378 (2008) 243–253monoclonal anti-PCBP2 antibody showed that the PCBP2 linker
augments binding to poliovirus stem-loop IV RNA via a mechanism
that is not inhibited by addition of an antibody speciﬁc to the linker
domain. The super-shifted RNP complex observed in the mobility shift
assay supports our hypothesis that the nine additional amino acids of
the PCBP2 linker allow steric ﬂexibility because even when complexedwith the RNA, the linker is presented in a way that is able to be
recognized by the antibody.
Our in vitro translation assays revealed that the addition of either a
monoclonal anti-PCBP2 or a polyclonal anti-PCBP antibody did not
inhibit poliovirus IRES-mediated translation (data not shown). We did
not expect the monoclonal anti-PCBP2 antibody to inhibit poliovirus
Fig. 6.Monoclonal antibody targeting the linker region of PCBP2 does not interfere with binding to stem-loop IV RNA. A. Puriﬁed, recombinant PCBP1/PCBP2 chimeric proteins (1 μg)
were resolved by SDS-PAGE and stained with Coomassie blue (upper panel). Western blot analysis of the PCBP1/PCBP2 chimeric proteins (lower panel). PCBP1/PCBP2 chimeric
proteins (1 μg) were resolved by SDS-PAGE, transferred to a PVDF membrane, and probed with a monoclonal anti-PCBP2 antibody. Only proteins that contain the PCBP2 linker are
detected by the antibody (shown by the arrow). B. Mobility shift assay of recombinant PCBP2 and poliovirus stem-loop IV RNAwith the addition of a monoclonal or polyclonal anti-
PCBP2 IgG. In vitro transcribed [32P] UTP-labeled poliovirus stem-loop IV RNA at a ﬁnal concentration of 1 nM was incubated with 50 or 100 nM of puriﬁed recombinant PCBP2 for
10 min at 30 °C. 1 μg of antibody was then added to the reaction and incubated for an additional 10 min at 30 °C. The reaction was then resolved by native polyacrylamide gel
electrophoresis. Lane 1 is the RNA alone. Lanes 2–3 show the incubation of the RNA in the presence of themonoclonal or polyclonal anti-PCBP2 IgG. Lanes 4–5 show ribonucleoprotein
complexes formed by the interaction of PCBP2with the RNA, as indicated by the PCBP2/stem-loop IV RNP complexes arrow. Lanes 6–7 show the super-shifted RNP complexmediated
by themonoclonal anti-PCBP2 antibody, as indicated by the super-shifted RNP complex arrow. Lanes 8–9 show that the polyclonal anti-PCBP2 antibody did not super-shift the PCBP2-
poliovirus stem-loop IV RNP complex.
251P. Sean et al. / Virology 378 (2008) 243–253translation, because themobility shift assay showed that evenwhen it is
complexed with the antibody, PCBP2 can still bind to poliovirus stem-
loop IV RNA. For the polyclonal anti-PCBP antibody, we predicted that
the antibody recognizes epitope(s) that overlap with an RNA-binding
domain, so the antibodymight inhibit translation; however, thiswasnot
observed. A possible explanation for the lack of translation inhibition
might be due to the presence of multiple epitopes recognized by the
polyclonal antibody that do not interferewith the activity of the protein.
Taken together, the data from these experiments clearly support our
hypothesis that the PCBP2 linker is the domain responsible for thedifferential ability of PCBP2 to bind poliovirus stem-loop IV RNA and
subsequentlymediate cap-independent translation of the viral genome.
Finally, to further verify our hypothesis that the differential
binding activity to poliovirus stem-loop IV RNA is due to the PCBP2
linker, it will be important to identify other RNA secondary structures
that display differential binding afﬁnities for PCBP1 and PCBP2. The
observed binding differences between PCBP1 and PCBP2 on RNA
secondary structures may potentially be a broader mechanism reg-
ulating stability or translation inhibition of cellular mRNAs. Ulti-
mately, co-crystallization structures of intact PCBP1 and PCBP2 with
252 P. Sean et al. / Virology 378 (2008) 243–253poliovirus stem-loop IV RNA will be required to deﬁne the direct
interaction between these proteins and the RNA.
Materials and methods
Plasmid design
PCBP1 and PCBP2 sequences were cloned into pET22 expression
vector from pQE30-PCBP1 and pQE30-PCBP2 (Blyn et al., 1996) by PCR
ampliﬁcation using N-terminal and C-terminal primers with NdeI and
XhoI restriction sites, respectively. PCR site-directed mutagenesis was
carried out to introduce silent NheI and XhoI restrictions sites in the
KH2/Linker and Linker/KH3 interface, respectively. PCBP1-Linker and
PCBP2-Linker proteins were generated by exchanging the cleavage
products of NdeI and NheI digestion of pET22-PCBP1 and pET22-
PCBP2. Plasmids encoding PCBP1-Linker/KH3 and PCBP2-Linker/KH3
proteins were generated by digestion of pET22-PCBP1 and pET22-
PCBP2. PCBP1-Linker/P2B and PCBP2-Linker/P1B were generated by
exchanging the cleavage products of XhoI digestion of PCBP1-Linker
and PCBP2-Linker.
Protein puriﬁcation
The pET22-PCBP1/PCBP2 chimeric plasmids were transformed into
E. coli BL-21 cells. We inoculated 1 l of M9 media with 1 ml of
overnight culture. The cells were grown at 37 °C until the culture
reached an absorbance of OD600=0.2. Protein expression was induced
by addition of 1 mM IPTG. The bacteria were grown for an additional
3 h at 18 °C and then pelleted by centrifugation. The bacterial pellet
was resuspended in 20 ml of phosphate buffer (50 mM phosphate pH
7.0, 5% glycerol, and 300 mM NaCl) and lysed by sonication. The
supernatant was adjusted to 20% ammonium sulfate and centrifuged
to pellet the protein precipitate. The ammonium sulfate precipitate
was resuspended in 10 ml of phosphate buffer and dialyzed overnight
against 1 l of phosphate buffer. The proteinwas batch bound in 1ml of
bed volume of Ni2+sepharose resin (Amersham). The resin was loaded
onto a column andwashedwith 50ml of 20mM imidazole-phosphate
buffer and eluted with 200 mM imidazole-phosphate buffer. The
proteins were dialyzed in initiation buffer (5 mM Tris–Cl, 25 mM KCl,
0.5 mM DTT, 0.05 mM EDTA and 5% glycerol) prior to use in mobility
shift assays or in vitro translation assays.
HeLa S10 preparation
The HeLa S10 cytoplasmic extracts were prepared with slight
modiﬁcations following the protocol published in Barton and
Flanegan, 1993. Brieﬂy, 6 l of HeLa suspensions cells were pelleted
and resuspended in wash buffer (35 mM HEPES pH 7.4, 146 mM NaCl
and 11 mM glucose) and re-pelleted. The HeLa cell pellet was then
resuspended in hypotonic buffer (20 mM HEPES pH 7.4, 10 mM KCl,
1.5 mMMgOAc, and 1 mM DTT) and allowed to swell for 20 min. Cells
were lysed by Dounce homogenization, and the extract was adjusted
by adding 1/10 of the extract volume of post-lysis buffer (20 mM
HEPES pH 7.4, 120 mM KOAc, 4 mM MgOAc, and 5 mM DTT). CaCl2
(1 mM) and micrococcal nuclease (2 mg/ml) were added and
incubated for 15 min at 14 °C, followed by addition of EGTA (4 mM).
The extract was stored in liquid N2.
PCBP depletion
The HeLa S10 cytoplasmic extracts were depleted of PCBP by RNA
afﬁnity chromatography, as described (Walter et al., 1999). Depletion
of PCBP from the extract was veriﬁed by Western Blot analysis using
the monoclonal anti-PCBP2 antibody. The PCBP-depleted extracts
were stored in liquid N2. Mock-depleted extracts were generated as
described (Walter et al., 1999).Antibody puriﬁcation
The IgG fraction frompolyclonal PCBP antibodies was puriﬁed from
the serum using DEAE-Afﬁgel-Blue (Bio-Rad) chromatography. Brieﬂy,
rabbit serum was loaded onto the column in starting buffer (20 mM
Tris–HCl pH 8 and 25mMNaCl) and the IgG fractions were elutedwith
the same buffer. Pooled peak protein fractions were adjusted to 50%
ammonium sulfate for precipitation. The ammonium sulfate pre-
cipitate was resuspended in 1 ml of initiation buffer and dialyzed in
the same buffer. Production of the monoclonal anti-PCBP2 antibody
was carried out by Cell Essentials (Boston). The IgG was puriﬁed from
the hybridoma supernatant under the same conditions as described
above for the polyclonal antibody.
In vitro transcription
Radio-labeled poliovirus RNAs were generated by in vitro T7
polymerase (New England) transcription using [32P] labeled UTP (GE
Health Sciences). The poliovirus stem-loop I and IV transcription
templates were generated by DdeI digestion of pT7-PV1 and HindIII
digested pT220–460, respectively. Poliovirus stem-loop I RNA was
puriﬁed by electrophoresis in an 8% polyacrylamide gel in the
presence of 6 M urea. Radio-labeled poliovirus stem-loop I RNA was
excised from the gel and eluted with oligo elution buffer (500 mM
NH4OAc, 1 mM EDTA and 0.1% SDS). The eluent was subjected to
phenol/chloroform extraction and ethanol precipitation. Poliovirus
stem-loop IV RNA was puriﬁed by Chromaspin chromatography
(Clonetech), phenol/chloroform extraction, and ethanol precipitation.
Mobility shift assays
PCBP1/PCBP2 chimeric proteins were pre-incubated (at a ﬁnal
concentration of 50 or 100 nM) with BSA (1 mg/ml), yeast tRNA
(0.8mg/ml) and binding buffer (5mMHEPES pH 7.5, 25mMKCl, 2mM
MgCl2, 0.1mMEDTA, 2mMDTT, and 4% glycerol) up to a volume of 9 μl
for 10 min at 30 °C. Then 1 μl of radio-labeled poliovirus stem-loop I or
IV RNA (at a ﬁnal concentration of 1 or 0.1 nM) was added and the
reaction was incubated for an additional 10 min at 30 °C. The reaction
was adjusted with 10% glycerol and resolved by native glycerol-
polyacrylamide (4%) gel electrophoresis.
GST pull-down assays
GST-PCBP2 protein was expressed and puriﬁed using the same
conditions as described for the PCBP1/PCBP2 chimeric proteins except
that it was afﬁnity puriﬁed by using Glutathione-sepharose 4B
(Amersham). The pull-down assays consisted of 100 μl 50%
glutathione-sepharose 4B, 1 μg GST-PCBP2, and 2.5 μg of PCBP1/
PCBP2 chimeric proteins (up to a total volume of 200 μl) incubated on
ice for 1 h (vortexed at 20 min intervals). For the GST control, we used
0.4 μg GST per reaction. The reactions were then pelleted by
centrifugation for 2 min at 3000 ×g and washed three times in
TENN buffer (50 mM Tris–HCl pH 7.5, 5 mM EDTA, 100 mM NaCl and
0.5% NP-40). The GST pull-down reactions were resolved by 12.5%
SDS-polyacrylamide gel electrophoresis followed by silver staining.
In vitro translation assay and luciferase assay
The in vitro translation reactions were carried out according to
Walter et al.,1999. Brieﬂy, the translation reaction consisted of 60%HeLa
S10 cytoplasmic extract,1 μl of all-4-mix (1mMATP, 250 μMCTP, 250 μM
GTP, and 250 μM UTP, 16 mM HEPES pH 7.4, 60 mM KOAc, 30 mM
creatine-phosphate, and 400 μg creatine kinase), 50 fmol of PV 5′NCR-
luciferase RNA, 100 nM PCBP1/PCBP2 chimeric protein, and initiation
buffer for a total volume of 10 μl. The reactionwas incubated for 2.5 h at
30 °C. Translationwas stopped by addition of 10 μl of passive lysis buffer
253P. Sean et al. / Virology 378 (2008) 243–253(Promega). Translation efﬁciency was determined by measuring the
light emission of 10 μl of the total in vitro translation reaction in 50 μl of
luciferin substrate (Promega) in a luminometer (Berthold).
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